Filtronic hits all-time high on late st spacex order

London’s Aim small-cap market is down 40% since mid 2021, but within that there has been a wide disparity of outcomes. Many 2021-vintage initial public offerings (IPOs) are down 80% or more. Yet one A

HOW AI IS SUPERCHARGING THE SECTOR

Trade tariffs, the Russia-Ukraine and the Israel-Palestine crises are all issues F&C’s Paul Niven takes in his stride

Companies in the news and how they were assessed

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

CITY